The dysexecutive syndrome of Alzheimer's disease: the GREFEX study

J Alzheimers Dis. 2014;42(4):1203-8. doi: 10.3233/JAD-140585.

Abstract

Background: Dysexecutive disorders are common in early-stage Alzheimer's disease (AD) but have yet to be characterized in detail.

Objective: The objectives of the present study based on validated diagnostic criteria were to determine the frequency and characterize the profile of behavioral and cognitive dysexecutive disorders in AD.

Methods: 102 patients with AD (mild: n = 92; moderate: n = 10; mean MMSE score: 23.2) were examined with the GREFEX battery. Neuropsychological data were interpreted within a validated framework based on the performance levels of 780 control participants from the GREFEX study.

Results: Dysexecutive syndrome was observed in 87.5% (95%CI: 79-96) of the AD patients (p = 0.0001). The dysexecutive disorder profile was characterized by prominent impairments of planning, inhibition flexibility and generation in the cognitive domain (p = 0.0001 as compared to controls for all) and global hypoactivity in the behavioral domain (p = 0.0001 as compared to controls).

Conclusions: Dysexecutive syndrome is observed in over 80% of AD patients and has a distinct profile.

Keywords: Alzheimer disease; attention; dementia; executive function; mild cognitive impairment.

MeSH terms

  • Aged
  • Alzheimer Disease / epidemiology
  • Alzheimer Disease / psychology*
  • Attention
  • Executive Function*
  • Female
  • Humans
  • Male
  • Motor Activity
  • Neuropsychological Tests